Prenetics Global Ltd. (PRE) Danny Yeung, CEO

A leading health

sciences company, is dedicated to advancing consumer and clinical health. Our

consumer initiatives is led by IM8, a new health and wellness brand. Our

clinical division is led by Insighta, our $200

million joint venture with renowned scientist Prof. Dennis Lo, focused on multi-cancer early detection

technologies. This is followed by ACT Genomics, which has achieved FDA

clearance for comprehensive genomic profiling of solid tumors, and CircleDNA,

which uses NGS to offer comprehensive DNA tests. Each of Prenetics' units

synergistically enhances our global impact on health, embodying our commitment

to 'enhancing life through science'.